GLP-1s

Explore GLP-1 compounds, comparisons, and practical guidance.

Download PeptideFox on the App StoreDownload PeptideFox on the App Store

Compare GLP-1 Compounds

View side-by-side compound profiles, mechanisms, dosing context, and practical use-case breakdowns.

Open tool

Browse other categories:PeptidesProtocolsGuides

Compound Guides

SemaglutideOzempicWegovy

Semaglutide dosing ranges from 0.25mg to 2.4mg a week. Understand how much weight loss to expect by dose, side effects during titration, and if Ozempic or Wegovy is right for you.

Read guide

TirzepatideMounjaroZepbound

Tirzepatide dosing ranges from 2.5mg to 15mg weekly. See what the trials show for weight loss, how side effects compare to semaglutide, and whether Mounjaro or Zepbound makes sense for you.

Read guide

RetatrutideTriple-Agonist GLP-1

Retatrutide is the next evolution of Ozempic and Mounjaro — hitting GLP-1, GIP (insulin), and glucagon (liver) receptors simultaneously — fundamentally altering metabolic health. Clinical weight loss and fat-reduction data, dosing protocols, and what to expect.

Read guide

Deep Dives

GLP-1s and Cholesterol

GLP-1 drugs also improve your lipid panel—lowering triglycerides, shifting LDL, and reducing liver fat. What the trials show for semaglutide, tirzepatide, and retatrutide.

Read guide

Oral GLP-1 OptionsWegovy PillOrforglipron

There's now a pill version of semaglutide, and orforglipron is coming. How they compare on weight loss, side effects, and cost—and who should consider pills over injections.

Read guide